A multicentre, randomized, single-blind comparison of topical clindamycin 1%/benzoyl peroxide 5% once-daily gel versus clindamycin 1% twice-daily gel in the treatment of mild to moderate acne vulgaris in Chinese patients

• Published in: Journal of the European Academy of Dermatology and Venereology Vol. 30; no. 7; pp. 1176 - 1182
• Main Authors: Xu, J.H., Lu, Q.J., Huang, J.H., Hao, F., Sun, Q.N., Fang, H., Gu, J., Dong, X.Q., Zheng, J., Luo, D., Li, F.Q., Wang, G., Gu, H., Tian, H.Q., Yang, H.L., Xi, L.Y., Li, M., Zheng, M., Wu, Y., Tu, Y.T., He, Y.L., Zhao, G., Sheng, W.X., Li, J., Hamedani, A.G.
• Format: Journal Article
• Language: English
• Published: England Blackwell Publishing Ltd 01.07.2016
• Subjects: Acne Vulgaris - drug therapy; Administration, Topical; Adolescent; Adult; Benzoyl Peroxide - administration & dosage; Child; China; Clindamycin - administration & dosage; Female; Gels; Humans; Male; Middle Aged; Single-Blind Method; Young Adult

Background Acne vulgaris affects up to 54% of Chinese adolescents. Combination therapy has become the recommended standard of care for acne. Objective The aim of this study was to compare the efficacy and safety of clindamycin (1%) and benzoyl peroxide (5%) (CDP/BPO) gel once daily vs. clindamycin (...